Home NDC 55289-460 Diflunisal
Product NDC 55289-460
11-digit product format 552890460
Labeler code 55289
Product ID 55289-460_7c1fbdf5-8b1a-6114-e053-2a91aa0aa2e4
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Diflunisal
Dosage form TABLET, FILM COATED
Route ORAL
Labeler PD-Rx Pharmaceuticals, Inc.
Application ANDA073673
Marketing category ANDA
Marketing start 1992-11-01
Marketing end 0000-00-00
Substance DIFLUNISAL
Active strength 500 mg/1
Pharmacologic classes Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag No
Listing certified through 2019-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 60 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A073673-001 DIFLUNISAL DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A073673-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 c2088c7a36db…2026-09-14 22:38:34 2026-08 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 84e616aacf4f…2026-08-18 06:07:40 2026-07 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A073673-001 DIFLUNISAL 500MG TABLET / ORAL AB RS 1992-07-31 3a93d1ddd44b…
Observed Orange Book normalized TE history# Normalized TE history page 2 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product TE code Order Source SHA-256 2022-10-28 04:53 UTC 2022-10 A073673-001 AB 1 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A073673-001 AB 1 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A073673-001 AB 1 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A073673-001 AB 1 a50c72e98297…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Diflunisal DIFLUNISAL Teva Pharmaceuticals USA, Inc. 7a78bb38-14d8-4a90-b883-482d4cebf716 2024-07-16 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 073673 application number: ANDA073673